Advancements of Targeted Therapy for EGFR Mutations in NSCLC
Oct 12, 2022 ·
3m 13s
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Dr. Chul Kim gives a brief history of targeted therapies, and discusses EGFR-TKIs.
Information
| Author | cancerGRACE |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
